Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (May 7, 2013)
-
-
-
Business Wire (Apr 29, 2013)
-
Business Wire (Apr 25, 2013)
-
-
-
-
-
-
-
Business Wire (Mar 14, 2013)
-
-
-
Business Wire (Mar 6, 2013)
-
Business Wire (Mar 1, 2013)
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
Osiris Therapeutics: Still The Best Bet In Regenerative MedicineScience-Of-Aging • Tue, Nov 27, 2012 -
-
-
-
-
Sirus XM: Year In Review And 2012 OutlookPragmatic Bear • Wed, Dec 28, 2011 -
-
Expiration Trade Behind Osiris ActivityoptionMONSTER • Fri, Nov 20, 2009 -
Optimistic on Osiris TherapeuticsZacks Investment Research • Fri, May 8, 2009 -
-
Osiris: Positive Heart Drug Data Boosts StockHerb Greenberg • Tue, Mar 27, 2007
-
Osiris: Knee Replacement Drug A BustHerb Greenberg • Tue, Feb 13, 2007
-
Osiris: Good News (But A Few People Died)Herb Greenberg • Wed, Dec 13, 2006
-
Osiris Therapeutics, Inc. Q1 2010 Earnings Call TranscriptFri, May 7, 2010
-
Osiris Therapeutics, Inc. Q4 2008 Earnings Call TranscriptFri, Feb 27, 2009
-
Osiris Therapeutics, Inc. Q1 2008 Earnings Call TranscriptFri, May 30, 2008
-
Osiris Therapeutics, Inc. Q4 2007 Earnings Call TranscriptThu, Feb 28, 2008
-
Osiris Therapeutics, Inc Q3 2007 Earnings Call TranscriptTue, Nov 13, 2007
-
Business Wire (May 7, 2013)
-
Business Wire (Apr 29, 2013)
-
Business Wire (Apr 25, 2013)
-
Business Wire (Mar 14, 2013)
-
at MarketWatch.com (Mar 6, 2013)
-
Business Wire (Mar 6, 2013)
-
Business Wire (Mar 1, 2013)
-
Business Wire (Feb 22, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Feb 18, 2013)
-
Business Wire (Nov 20, 2012)
-
Business Wire (Nov 5, 2012)
-
Business Wire (Oct 29, 2012)
-
Business Wire (Oct 22, 2012)
-
Business Wire (Sep 28, 2012)
-
Business Wire (Sep 28, 2012)
-
Business Wire (Sep 20, 2012)
-
Business Wire (Sep 19, 2012)
-
Business Wire (Jul 30, 2012)
-
Business Wire (Jul 23, 2012)
OSIR vs. ETF Alternatives
Company Description
We are a leading stem cell therapeutic company headquartered in Columbia, Maryland and focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas. We were incorporated in Delaware in April 2002. Our predecessor company was... More
